GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7

Cell Metabolism

Volumn 21, Issue 3, 2015, Pages 379-391

  Koehler, Jacqueline A ^a   Baggio, Laurie L ^a   Yusta, Bernardo ^a   Longuet, Christine ^a   Rowland, Katherine J ^b   Cao, Xiemin ^a   Holland, Dianne ^a   Brubaker, Patricia L ^b   Drucker, Daniel J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 2; KERATINOCYTE GROWTH FACTOR; LIRAGLUTIDE; SOMATOMEDIN C; FGF7 PROTEIN, MOUSE; INCRETIN; PEPTIDE; SOMATOMEDIN C RECEPTOR; VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON POLYP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INTESTINAL GROWTH; LARGE INTESTINE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMALL INTESTINE; TISSUE GROWTH; AGONISTS; ANIMAL; C57BL MOUSE; CARCINOGENESIS; COLON; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; COLON; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 7; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; INCRETINS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; PEPTIDES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; VENOMS;

EID: 84924428027     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.02.005     Document Type: Article

References (53)

1. S. Ali, B.J. Lamont, M.J. Charron, and D.J. Drucker Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis J. Clin. Invest. 121 2011 1917 1929
2. S. Ali, J.R. Ussher, L.L. Baggio, M.G. Kabir, M.J. Charron, O. Ilkayeva, C.B. Newgard, and D.J. Drucker Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction Molecular Metabolism 4 2015 132 143
3. H. Ashrafian, K. Ahmed, S.P. Rowland, V.M. Patel, N.J. Gooderham, E. Holmes, A. Darzi, and T. Athanasiou Metabolic surgery and cancer: protective effects of bariatric procedures Cancer 117 2011 1788 1799
4. R. Boismenu, and W.L. Havran Modulation of epithelial cell growth by intraepithelial gamma delta T cells Science 266 1994 1253 1255
5. E.E. Calle, and M.J. Thun Obesity and cancer Oncogene 23 2004 6365 6378
6. J.E. Campbell, and D.J. Drucker Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab. 17 2013 819 837
7. Y. Chen, K. Chou, E. Fuchs, W.L. Havran, and R. Boismenu Protection of the intestinal mucosa by intraepithelial gamma delta T cells Proc. Natl. Acad. Sci. USA 99 2002 14338 14343
8. M. Derogar, M.A. Hull, P. Kant, M. Östlund, Y. Lu, and J. Lagergren Increased risk of colorectal cancer after obesity surgery Ann. Surg. 258 2013 983 988
9. D.J. Drucker, and B. Yusta Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2 Annu. Rev. Physiol. 76 2014 561 583
10. D.J. Drucker, P. Erlich, S.L. Asa, and P.L. Brubaker Induction of intestinal epithelial proliferation by glucagon-like peptide 2 Proc. Natl. Acad. Sci. USA 93 1996 7911 7916
11. D.J. Drucker, Q. Shi, A. Crivici, M. Sumner-Smith, W. Tavares, M. Hill, L. DeForest, S. Cooper, and P.L. Brubaker Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV Nat. Biotechnol. 15 1997 673 677
12. P.E. Dubé, C.L. Forse, J. Bahrami, and P.L. Brubaker The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice Gastroenterology 131 2006 589 605
13. R.W. Gelling, X.Q. Du, D.S. Dichmann, J. Romer, H. Huang, L. Cui, S. Obici, B. Tang, J.J. Holst, and C. Fledelius Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice Proc. Natl. Acad. Sci. USA 100 2003 1438 1443
14. R.A. Goodlad, N. Mandir, K. Meeran, M.A. Ghatei, S.R. Bloom, and R.J. Playford Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration? Regul. Pept. 87 2000 83 90
15. L.C. Greaves, S.L. Preston, P.J. Tadrous, R.W. Taylor, M.J. Barron, D. Oukrif, S.J. Leedham, M. Deheragoda, P. Sasieni, and M.R. Novelli Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission Proc. Natl. Acad. Sci. USA 103 2006 714 719
16. M. Grigoryan, M.H. Kedees, M.J. Charron, Y. Guz, and G. Teitelman Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides Endocrinology 153 2012 3076 3088
17. P. Kant, A. Sainsbury, K.R. Reed, S.G. Pollard, N. Scott, A.R. Clarke, P.L. Coletta, and M.A. Hull Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB Gut 60 2011 893 901
18. M.H. Kedees, Y. Guz, M. Grigoryan, and G. Teitelman Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor Peptides 48 2013 36 44
19. H. Kissow, B. Hartmann, J.J. Holst, N.E. Viby, L.S. Hansen, M.M. Rosenkilde, K.J. Hare, and S.S. Poulsen Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice Regul. Pept. 179 2012 91 100
20. G.Y. Lai, Y. Park, P. Hartge, A.R. Hollenbeck, and N.D. Freedman The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study J. Clin. Endocrinol. Metab. 98 2013 E497 E502
21. B.J. Lamont, Y. Li, E. Kwan, T.J. Brown, H. Gaisano, and D.J. Drucker Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice J. Clin. Invest. 122 2012 388 402
22. S.-J. Lee, J. Lee, K.K. Li, D. Holland, H. Maughan, D.S. Guttman, B. Yusta, and D.J. Drucker Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis Endocrinology 153 2012 1141 1151
23. C. Li, L.S. Balluz, E.S. Ford, C.A. Okoro, J. Tsai, and G. Zhao Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System Diabetes Care 34 2011 1365 1368
24. C.F. Li, H.L. He, J.Y. Wang, H.Y. Huang, T.F. Wu, C.H. Hsing, S.W. Lee, H.H. Lee, J.L. Fang, W.T. Huang, and S.H. Chen Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy J. Clin. Pathol. 67 2014 1056 1061
25. N.C. Luetteke, H.K. Phillips, T.H. Qiu, N.G. Copeland, H.S. Earp, N.A. Jenkins, and D.C. Lee The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase Genes Dev. 8 1994 399 413
26. S. Madsbad, C. Dirksen, and J.J. Holst Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery Lancet Diabetes Endocrinol 2 2014 152 164
27. K.B. Madsen, C. Askov-Hansen, R.M. Naimi, C.F. Brandt, B. Hartmann, J.J. Holst, P.B. Mortensen, and P.B. Jeppesen Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study Regul. Pept. 184 2013 30 39
28. Y. Matsuda, T. Ishiwata, K. Yamahatsu, K. Kawahara, M. Hagio, W.X. Peng, T. Yamamoto, N. Nakazawa, T. Seya, Y. Ohaki, and Z. Naito Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer Cancer Lett. 309 2011 209 219
29. J. Molina, R. Rodriguez-Diaz, A. Fachado, M.C. Jacques-Silva, P.O. Berggren, and A. Caicedo Control of insulin secretion by cholinergic signaling in the human pancreatic islet Diabetes 63 2014 2714 2726
30. R. Nilsson, M. Jain, N. Madhusudhan, N.G. Sheppard, L. Strittmatter, C. Kampf, J. Huang, A. Asplund, and V.K. Mootha Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer Nat. Commun. 5 2014 3128
31. I. Nishisho, Y. Nakamura, Y. Miyoshi, Y. Miki, H. Ando, A. Horii, K. Koyama, J. Utsunomiya, S. Baba, and P. Hedge Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 1991 665 669
32. C. Orskov, B. Hartmann, S.S. Poulsen, J. Thulesen, K.J. Hare, and J.J. Holst GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors Regul. Pept. 124 2005 105 112
33. J.M. Otte, F. Schmitz, T. Banasiewicz, M. Drews, U.R. Fölsch, and K.H. Herzig Expression of keratinocyte growth factor and its receptor in colorectal cancer Eur. J. Clin. Invest. 30 2000 222 229
34. N. Panjwani, E.E. Mulvihill, C. Longuet, B. Yusta, J.E. Campbell, T.J. Brown, C. Streutker, D. Holland, X. Cao, L.L. Baggio, and D.J. Drucker GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice Endocrinology 154 2013 127 139
35. G. Pathuri, Q. Li, A. Mohammed, H. Gali, J.T. Pento, and C.V. Rao Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice Bioorg. Med. Chem. Lett. 24 2014 1380 1382
36. A. Plamboeck, S. Veedfald, C.F. Deacon, B. Hartmann, A. Wettergren, L.B. Svendsen, S. Meisner, C. Hovendal, F.K. Knop, T. Vilsbøll, and J.J. Holst Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty Eur. J. Endocrinol. 169 2013 187 201
37. A. Plamboeck, S. Veedfald, C.F. Deacon, B. Hartmann, A. Wettergren, L.B. Svendsen, S. Meisner, C. Hovendal, T. Vilsbøll, F.K. Knop, and J.J. Holst The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty Am. J. Physiol. Gastrointest. Liver Physiol. 304 2013 G1117 G1127
38. C. Pyke, R.S. Heller, R.K. Kirk, C. Orskov, S. Reedtz-Runge, P. Kaastrup, A. Hvelplund, L. Bardram, D. Calatayud, and L.B. Knudsen GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody Endocrinology 155 2014 1280 1290
39. F. Reimann, G. Tolhurst, and F.M. Gribble G-protein-coupled receptors in intestinal chemosensation Cell Metab. 15 2012 421 431
40. P. Richards, H.E. Parker, A.E. Adriaenssens, J.M. Hodgson, S.C. Cork, S. Trapp, F.M. Gribble, and F. Reimann Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model Diabetes 63 2014 1224 1233
41. R. Rodriguez-Diaz, R. Dando, M.C. Jacques-Silva, A. Fachado, J. Molina, M.H. Abdulreda, C. Ricordi, S.D. Roper, P.O. Berggren, and A. Caicedo Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans Nat. Med. 17 2011 888 892
42. K.J. Rowland, S. Trivedi, D. Lee, K. Wan, R.N. Kulkarni, M. Holzenberger, and P.L. Brubaker Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion Gastroenterology 141 2011 2166 2175.e7
43. A. Sakthianandeswaren, M. Christie, C. D'Andreti, C. Tsui, R.N. Jorissen, S. Li, N.I. Fleming, P. Gibbs, L. Lipton, and J. Malaterre PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis Cancer Res. 71 2011 3709 3719
44. L.A. Scrocchi, T.J. Brown, N. MaClusky, P.L. Brubaker, A.B. Auerbach, A.L. Joyner, and D.J. Drucker Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene Nat. Med. 2 1996 1254 1258
45. L. Simonsen, S. Pilgaard, C. Orskov, M.M. Rosenkilde, B. Hartmann, J.J. Holst, and C.F. Deacon Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats Am. J. Physiol. Gastrointest. Liver Physiol. 293 2007 G288 G295
46. L. Sjöström, A. Gummesson, C.D. Sjöström, K. Narbro, M. Peltonen, H. Wedel, C. Bengtsson, C. Bouchard, B. Carlsson, S. Dahlgren Swedish Obese Subjects Study Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial Lancet Oncol. 10 2009 653 662
47. H.J. Snippert, A.G. Schepers, J.H. van Es, B.D. Simons, and H. Clevers Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion EMBO Rep. 15 2014 62 69
48. J. Terzić, S. Grivennikov, E. Karin, and M. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101 2114, e5
49. M. Watanabe, T. Ishiwata, K. Nishigai, Y. Moriyama, and G. Asano Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer Pathol. Int. 50 2000 363 372
50. A. Wichmann, A. Allahyar, T.U. Greiner, H. Plovier, G.O. Lundén, T. Larsson, D.J. Drucker, N.M. Delzenne, P.D. Cani, and F. Bäckhed Microbial modulation of energy availability in the colon regulates intestinal transit Cell Host Microbe 14 2013 582 590
51. M. Yoshino, T. Ishiwata, M. Watanabe, O. Komine, T. Shibuya, A. Tokunaga, and Z. Naito Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer Oncol. Rep. 13 2005 247 252
52. B. Yusta, D. Holland, J.A. Koehler, M. Maziarz, J.L. Estall, R. Higgins, and D.J. Drucker ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut Gastroenterology 137 2009 986 996
53. J. Zhang, J. Fan, S. Venneti, J.R. Cross, T. Takagi, B. Bhinder, H. Djaballah, M. Kanai, E.H. Cheng, and A.R. Judkins Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion Mol. Cell 56 2014 205 218